Correspondence 0001104659-25-013910 from Petros Pharmaceuticals, Inc. (PTPI)

Petros Pharmaceuticals, Inc.
Date: Feb. 14, 2025 · CIK: 0001815903 · Accession: 0001104659-25-013910

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-284495

Date

February 14, 2025

Author

Not clearly detected

Form

CORRESP

Company

Petros Pharmaceuticals, Inc.

Letter

Dawson James Securities, Inc.

101 North Federal Highway, Suite 600

Boca Raton, Fl 33432

February 14, 2025

VIA EDGAR CORRESPONDENCE

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Re: Petros Pharmaceuticals, Inc.

Registration Statement on Form S-1/A

File No. 333-284495

Ladies and Gentlemen:

Reference is made to our letter, filed as correspondence via EDGAR on February 11, 2025, in which we requested the acceleration of the effective date of the above-referenced Registration Statement for 4:00 p.m., Eastern Time, on February 12, 2025, or as soon thereafter as practicable, in accordance with Rule 461 under the Securities Act of 1933, as amended.

We are no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of that effective date.

If you require any additional information with respect to this letter, please contact Ali Panjwani at (212) 326-0820 of Pryor Cashman LLP.

Very truly yours,
DAWSON JAMES SECURITIES, INC.

Show Raw Text

CORRESP
1
filename1.htm

Dawson
James Securities, Inc.

101 North
Federal Highway, Suite 600

Boca
Raton, Fl 33432

February 14, 2025

VIA EDGAR CORRESPONDENCE

    U.S. Securities and Exchange Commission

    Division of Corporation Finance

    100 F Street, N.E.

    Washington, D.C. 20549

 Re: Petros Pharmaceuticals, Inc.

                                            Registration Statement on Form S-1/A

    File No. 333-284495

Ladies and Gentlemen:

Reference is made to our letter,
filed as correspondence via EDGAR on February 11, 2025, in which we requested the acceleration of the effective date of the above-referenced
Registration Statement for 4:00 p.m., Eastern Time, on February 12, 2025, or as soon thereafter as practicable, in accordance with Rule
461 under the Securities Act of 1933, as amended.

We are no longer requesting
that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of that
effective date.

If you require any additional
information with respect to this letter, please contact Ali Panjwani at (212) 326-0820 of Pryor Cashman LLP.

    Very truly yours,

    DAWSON JAMES SECURITIES, INC.

    By:
     /s/ Robert D. Keyser, Jr.

    Robert D. Keyser, Jr.

    Chief Executive Officer

cc: M. Ali Panjwani, Esq.

  Pryor Cashman LLP

SecProbe.io